FACT II Acquisition Corp
$10.56
▲
0.15%
2026-04-21 06:46:01
NGM: FACT
Explore FACT II Acquisition Corp stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$256.83 M
Current Price
$10.56
52W High / Low
$10.7 / $10.04
Stock P/E
51.19
Book Value
$-0.35
Dividend Yield
—
ROCE
-1.21%
ROE
2.86%
Face Value
—
EPS
$0.21
Exp Qtr EPS
—
Sector
—
Industry
—
Employees
—
Beta
—
Debt / Equity
—
Current Ratio
27.11
Quick Ratio
27.11
Forward P/E
—
Price / Sales
—
Enterprise Value
—
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bank of Montreal | $151.36 | 17.21 | $107.34 B | 3.21% | — | 10.47% | $210.03 / $126.91 | $86.08 |
| 2. | Eli Lilly and Company | $921 | 40.12 | $868.52 B | 0.75% | 38.44% | 1.01% | $1,133.95 / $623.78 | $29.66 |
| 3. | Alphabet Inc. | $335.72 | 31.05 | $4,076.67 B | 0.25% | 26.2% | 35.71% | $349 / $146.1 | $34.35 |
| 4. | Cboe Global Markets, Inc. | NOT FOUND | — | — | 0.96% | 21.81% | 23.36% | $309.87 / $207.75 | $49.1 |
| 5. | Abbott Laboratories | $93.07 | 25.91 | $162.16 B | 2.6% | 11.47% | 12.96% | $139.06 / $93.92 | $30.02 |
| 6. | The Procter & Gamble Company | $142.68 | 21.14 | $332.05 B | 3.01% | 22.93% | 31.56% | $171.65 / $137.62 | $22.49 |
| 7. | McKesson Corporation | $837.14 | 24.1 | $102.52 B | 0.38% | 35.58% | -162.92% | $999 / $637 | $-10.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -1.06 M | -0.6 M | -0.2 M | -0.36 M | -0.98 M | — |
| Net Profit | 0.67 M | 1.27 M | 1.63 M | 1.45 M | 0.03 M | — |
| EPS in Rs | 0.04 | 0.07 | 0.09 | 0.08 | 0 | -0 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | |
|---|---|---|
| Sales | 0 M | — |
| Operating Profit | -2.23 M | — |
| Net Profit | 5.02 M | — |
| EPS in Rs | 0.27 | — |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | |
|---|---|---|
| Total Assets | 184.42 M | 178.22 M |
| Total Liabilities | 9.16 M | 7.97 M |
| Equity | 175.26 M | 170.24 M |
| Current Assets | 0.64 M | 1.54 M |
| Current Liabilities | 0.02 M | 0.12 M |
Cash Flow
Last available yearly cash flow history
| 2025 | |
|---|---|
| Operating CF | -0.9 M |
| Investing CF | 0 M |
| Financing CF | 0 M |
| Free CF | -0.9 M |
| Capex | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | |
|---|---|
| Revenue Growth % | — |
| Earnings Growth % | — |
| Profit Margin % | — |
| Operating Margin % | — |
| Gross Margin % | — |
| EBITDA Margin % | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.